Vogelxo, a new testosterone gel, just got approved by the FDA

[Nelson Vergel]

MAPLE GROVE, Minn., June 4, 2014- Upsher-Smith Laboratories, Inc., today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo (testosterone) gel for topical use CIII. The company is preparing to launch Vogelxo in the near future.